Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Four-year results using balloon-based brachytherapy to deliver accelerated partial breast irradiation with a 2-day dose fractionation schedule.
Wilkinson JB, Martinez AA, Chen PY, Ghilezan MI, Wallace MF, Grills IS, Shah CS, Mitchell CK, Sebastian E, Limbacher AS, Benitez PR, Brown EA, Vicini FA. Wilkinson JB, et al. Among authors: sebastian e. Brachytherapy. 2012 Mar-Apr;11(2):97-104. doi: 10.1016/j.brachy.2011.05.012. Epub 2011 Jul 2. Brachytherapy. 2012. PMID: 21727032 Clinical Trial.
High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable/intermediate-risk prostate cancer: preliminary toxicity data.
Ghilezan M, Martinez A, Gustason G, Krauss D, Antonucci JV, Chen P, Fontanesi J, Wallace M, Ye H, Casey A, Sebastian E, Kim L, Limbacher A. Ghilezan M, et al. Among authors: sebastian e. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):927-32. doi: 10.1016/j.ijrobp.2011.05.001. Epub 2011 Dec 23. Int J Radiat Oncol Biol Phys. 2012. PMID: 22197086
Five-Year Outcomes of a Single-Institution Prospective Trial of 19-Gy Single-Fraction High-Dose-Rate Brachytherapy for Low- and Intermediate-Risk Prostate Cancer.
Siddiqui ZA, Gustafson GS, Ye H, Martinez AA, Mitchell B, Sebastian E, Limbacher A, Krauss DJ. Siddiqui ZA, et al. Among authors: sebastian e. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1038-1044. doi: 10.1016/j.ijrobp.2019.02.010. Epub 2019 Feb 13. Int J Radiat Oncol Biol Phys. 2019. PMID: 30771408
Rates of rectal toxicity in patients treated with high dose rate brachytherapy as monotherapy compared to dose-escalated external beam radiation therapy for localized prostate cancer.
Parzen JS, Ye H, Gustafson G, Yan D, Martinez A, Chen PY, Ghilezan M, Sebastian E, Limbacher A, Krauss DJ. Parzen JS, et al. Among authors: sebastian e. Radiother Oncol. 2020 Jun;147:123-129. doi: 10.1016/j.radonc.2020.03.033. Epub 2020 Mar 31. Radiother Oncol. 2020. PMID: 32276193
Normal Tissue Integral Dose as a Result of Prostate Radiation Therapy: A Quantitative Comparison Between High-Dose-Rate Brachytherapy and Modern External Beam Radiation Therapy Techniques.
Grzywacz VP, Arden JD, Mankuzhy NP, Gustafson GS, Sebastian EA, Abbott VL, Walters KJ, Puzzonia JA, Limbacher AS, Hafron JM, Krauss DJ. Grzywacz VP, et al. Adv Radiat Oncol. 2022 Dec 27;8(3):101160. doi: 10.1016/j.adro.2022.101160. eCollection 2023 May-Jun. Adv Radiat Oncol. 2022. PMID: 36896212 Free PMC article.
139 results